|
Steven G Arless
Steven G Arless is a Canadian entrepreneur in the biomedical technology industry.[1] He directed and developed several medical device companies treating cardiovascular disease from inception through major financing and public stock offering, advancing new medical devices from R&D to commercialization and global sales, including CryoCath Technologies, CardioInsight and Resonant Medical.[2][3] He has served as CEO for a number of companies, most notably CryoCath Technologies (sold to Medtronic Inc. for $400 million CAD), Resonant Medical (sold to Elekta AB for $30 million), and CardioInsight (also sold to Medtronic for $100 million USD). Early life and educationArless was born in Montreal, Quebec on July 23, 1949. His father, an accountant, and his mother were immigrants to Canada from Lebanon.[4] Arless studied Chemistry and Engineering at McGill University, graduating with a BSc. in 1971.[1] Arless also completed his MBA at the John Molson School of Business at Concordia University in Montréal in 2008.[1] CareerArless is an angel investor in medical technology and is involved in mentorship and teaching of graduate students at McGill University and Concordia University and McGill University where he is a Professor of Practice.[1] In 1971, Arless worked with Smith & Nephew, a British medical equipment company for 17 years and served as president for five years.[4] He was CEO of the North American operations from 1986 to 1990.[4] In 1996, Arless became CEO of CryoSurge founded in 1995 and changed the name to CryoCath Technologies inc., in 1997, a company specializing in a cryoablation treatment for heart arrhythmia.[5] Arless served as president and CEO of CryoCath from its inception until 2006, when he resigned.[6] Arless relocated to Cleveland, Ohio in 2009 to become CEO of CardioInsight, a company marketing and advancing research in cardiovascular technology.[7][6] Arless stepped down from his position at CardioInsight in 2012.[8] Arless co-founded medical device company, Soundbite Medical Solutions, which fabricated wire devices to treat occlusions caused by coronary and peripheral artery disease with shockwaves.[9] Arless stepped down as CEO in 2017.[10] As of early 2018, Arless has been serving as MedTech Entrepreneur-in-Residence at Centech, a Montreal-based technology accelerator that strives to create new sustainable high tech business startups.[11] In late 2019, Arless co-founded and took the position as CEO of ViTAA Medical Solutions, a healthcare AI company specializing in 3D mapping of patients with aortic aneurysms that provide surgeons with clinical intelligence to guide therapy.[12][13] AwardsArless was awarded the Ernst & Young Entrepreneur of the Year award in 2005 for Health Sciences.[14] References
Information related to Steven G Arless |
||||||||||||
